The coronavirus disease 2019 pandemic is highlighting how independent community oncology practices are the best source for patients to receive care close to home, while also presenting several challenges for practices and their patients.
Barry Fortner, PhD
Advertisement
Articles by Barry Fortner, PhD
With the rise of oral oncolytic prescribing and development, more oncology practices are implementing in-office dispensing programs to provide a seamless treatment experience for patients.
Independent community oncologists play a vital role in cancer treatment for hundreds of thousands of Americans.
Advertisement
Latest Updated Articles
Making the Case for Medically Integrated DispensingNovember 23rd 2018
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Gedatolisib Plus Fulvestrant ± Palbociclib for Hormone Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer
2
Dr Cerchione on the FDA Approval of Subcutaneous Isatuximab in Myeloma
3
Frontline Sac-TMT Plus Pembrolizumab Meets PFS End Point in PD-L1–Negative, Nonsquamous NSCLC
4
Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer
5